Skip to content

Clinical study of Chitrakadi Vati (An Ayurvedic polyherbal formulation) in indigestion

Development and validation of Jatharagni Bala assessment tool and a clinical study to evaluate the effect of Chitrakadi Vati on Jathragni Bala in patients of Mandagni

Status
Active, not recruiting
Phases
Phase 2Phase 3
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2022/12/048277
Enrollment
60
Registered
2022-12-19
Start date
Unknown
Completion date
Unknown
Last updated
2023-01-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: K599- Functional intestinal disorder, unspecified

Interventions

None listed

Sponsors

National Institute of Ayurveda Deemed to be University Jaipur
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Patients having sign and symptoms of â??Mandagniâ?? according to classical text of Ayurveda. Patient with chronicity of less than 1 year

Exclusion criteria

Exclusion criteria: 1. Patients having associated cardiac disease, tuberculosis, diabetes mellitus, malignant hypertension, renal impairment, hypothyroidism, liver disorders, depression, cancers, acid peptic disorders, bleeding disorders, 2. Patients with history of long-term steroid and cytotoxic treatment. 3. Patients participated in any clinical trial within last six months.

Design outcomes

Primary

MeasureTime frame
Changes in Jatharagni Bala scoreTimepoint: at Baseline, and end of 14 days treatment

Secondary

MeasureTime frame
Changes in symptoms of MandagniTimepoint: At baseline and end of 14 days treatment

Countries

India

Contacts

Public ContactDr Bharat Padhar

National institute of Ayurveda, Deemed to be University, Jaipur

bcpadhar@gmail.com9638435942

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026